TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

TELA Bio, Inc., a medical technology company, will participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on November 17, 2022, at 1:30 PM ET.

Rhea-AI Summary

TELA Bio, Inc., a medical technology company, will participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on November 17, 2022, at 1:30 PM ET. The forum aims to showcase innovative soft-tissue reconstruction solutions that prioritize patient anatomy restoration. Interested parties can access the presentation live or archived at ir.telabio.com. TELA's mission focuses on leveraging the patient’s natural healing response while minimizing the use of synthetic materials.

Argus Session date unavailable

-7.19% session move Open Argus

Details

News Market Reaction – TELA

The recorded move for TELA in the trading session of this news was -7.19%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MALVERN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on November 17^th, 2022.

TELA’s management is scheduled to present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 17^th, 2022, at 1:30pm ET. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
332-895-3230
ir@telabio.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TELA Bio participate in the Canaccord MedTech Forum?

TELA Bio will participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on November 17, 2022, at 1:30 PM ET.

How can I access TELA Bio's presentation at the Canaccord Forum?

You can access TELA Bio's presentation live and archived at ir.telabio.com.

What is the focus of TELA Bio's technology?

TELA Bio focuses on innovative soft-tissue reconstruction solutions that optimize clinical outcomes by preserving and restoring the patient’s own anatomy.

What is TELA Bio's stock symbol?

The stock symbol for TELA Bio is TELA.